Tradition Wealth Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-962
Closed -$31K 705
2023
Q4
$31K Hold
962
﹤0.01% 747
2023
Q3
$34K Hold
962
﹤0.01% 693
2023
Q2
$37K Hold
962
﹤0.01% 710
2023
Q1
$36K Hold
962
﹤0.01% 700
2022
Q4
$41K Hold
962
0.01% 579
2022
Q3
$31K Buy
+962
New +$33.8K ﹤0.01% 642

Other funds holding GMAB

Tradition Wealth Management's GMAB Position: Q1 2024 in Review

Tradition Wealth Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 962 shares — an estimated $31K sold.

Tradition Wealth Management first reported a position in GMAB in Q3 2022 and held it in 6 quarters. The position peaked at $41K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Tradition Wealth Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Tradition Wealth Management sold 962 Genmab shares in Q1 2024, an estimated $31K.
  • Tradition Wealth Management first reported a position in Genmab in Q3 2022 and held it in 6 quarters.
  • Tradition Wealth Management's Genmab position peaked at $41K in Q4 2022.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.